Cabotegravir approval welcomed: now it must be made available as soon as possible
A simple injection six times a year can take us to the next stage in the fight against the HIV epidemic.
In all areas of our work, we seek to centre the voices of marginalised communities, to ensure that the needs and rights of everyone living with, or affected by, HIV are considered and addressed.
Without addressing deeply intrenched inequalities we will not be able to stop new HIV transmissions and end HIV stigma.
Working with the One Voice Network, the Unheard Voices partnership aims to end the structural inequalities and barriers that affect Black people living with or at risk of HIV. Often left behind, despite being disproportionately affected, so it is vital that Black communities lead these conversations.
A simple injection six times a year can take us to the next stage in the fight against the HIV epidemic.
We comment on the UKHSA’s latest HIV data.
To make the vision of the Plan a reality, we must see sustained investment in the NHS, stronger NHS partnerships with community organisations, and a continued focus on tackling inequalities.
As NICE prepares a final decision on long-acting injectable PrEP cabotegravir, National AIDS Trust calls for its approval as a way to tackle inequalities and to end new HIV cases.
PIP is a lifeline for thousands of people living with HIV – it has to be protected.
Daniel Fluskey, our Director of Policy, Research and Influencing takes a look back over what has been achieved in 2024, and what we still need to do as we head towards 2030.
A review of the experience of discrimination for people living with HIV in the UK
Understanding the challenges faced by Black people living with HIV in primary care
A literature review of studies on the needs of Black communities living with and impacted by HIV